Alyssa S Deppong, PHYSICIAN ASSISTANT Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 12500 Aurora Dr, Pleasant Prairie, WI 53158 Phone: 262-857-5000 |
News Archive
Obesity is a global pandemic, affecting about 40% of adults in the United States. There is an enormous unmet need for an effective weight-loss solution.
Service Employees International Union members and their families, members of the community and concerned citizens gathered in front of Congressman Roy Blunt's office to demand why he continues to put politics before Missouri families.
New research examines the validity of measures used to assess the quality of kidney-related care in the United States.
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved VIVITROL(naltrexone for extended-release injectable suspension) for the prevention of relapse to opioid dependence, following opioid detoxification.
Results from a Phase 2, 8-week dose-ranging study using low doses of atrasentan in patients with diabetic kidney disease were published this week in the Journal of the American Society of Nephrology. The published study results suggest that atrasentan, used in conjunction with renin-angiotensin system inhibitors, may reduce albuminuria (presence of protein in urine) for patients with type 2 diabetes.
› Verified 2 days ago